Amgen Inc. (AMGN)

245.49
NASDAQ
Prev Close 241.66
Day Low/High 240.02 / 246.84
52 Wk Low/High 177.05 / 264.97
Exchange NASDAQ
Shares Outstanding 582.17B
Market Cap 140.69B
P/E Ratio 19.16
Div & Yield N.A. (N.A)
Staying Long Apple Into Tuesday's Product Launch: Market Recon

Staying Long Apple Into Tuesday's Product Launch: Market Recon

My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

It becomes difficult for me to tell you where to run in these markets...

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Novice Trade: Amgen

Novice Trade: Amgen

Amgen calls just look too cheap to pass up here.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Biotechs: Adding to Radius Health, Flexion

Biotechs: Adding to Radius Health, Flexion

This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.

3 Best Ways to Play Amazon, Starbucks and Amgen After Earnings

3 Best Ways to Play Amazon, Starbucks and Amgen After Earnings

Here are 3 ways to play these 3 stocks on earnings.

Charting 3 Big Names After Earnings

Charting 3 Big Names After Earnings

How to play Amazon, Starbucks and Amgen on earnings news.

Biotech Stocks Rally on Biogen's Landmark Test

Biotech Stocks Rally on Biogen's Landmark Test

Investors might be finally recognizing the hidden value of the firms' drug research and development.

Amgen Is Ready to Breakout on the Upside

Amgen Is Ready to Breakout on the Upside

Let's go to the charts.

Jim Cramer: Move Over FANG, Long Live INJFANG

Jim Cramer: Move Over FANG, Long Live INJFANG

The Nasdaq hit an all-time high today, and It's Not Just FANG anymore.

Emboldened By Biotech Names

Emboldened By Biotech Names

For the trade, I'm opting to use the iShares Nasdaq Biotechnology ETF.

When the Stock Is the Only Option

When the Stock Is the Only Option

Options spreads aren't tradable with some small biotechs, making shares the only way to play.

Jim Cramer: Are Markets Getting Tired of Trump, Trade and Tariffs?

Jim Cramer: Are Markets Getting Tired of Trump, Trade and Tariffs?

Sooner or later, bargain hunters will say: 'Enough already. It can't be that bad.'

Feels Like the Semis Are Skating on Thin Ice: Market Recon

Feels Like the Semis Are Skating on Thin Ice: Market Recon

Forward looking valuations, except for Nvidia, are very low.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

These 2 Widely Held Stocks Look Good Short

These 2 Widely Held Stocks Look Good Short

Our 'bearish bets' show weak technical characteristics and have received recent quant downgrades.

Cramer vs. Chaikin: Amgen -- Be Careful of This Stock

Cramer vs. Chaikin: Amgen -- Be Careful of This Stock

TheStreet's Jim Cramer and Marc Chaikin, of Chaikin Analytics, spent an hour together at our offices talking all things markets. Listen to the whole conversation below. In the except above, they discuss Amgen and why Chaikin says to be careful of the stock.

The Shifting Price Action Continued Today

The Shifting Price Action Continued Today

The good news is that volatility is increasing. The bad news, for some, is that it moves in both directions.

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.

Cramer: Step Away and Get Your Clients Better Prices

Cramer: Step Away and Get Your Clients Better Prices

You mean to tell me if the buyers walked away for 10 minutes they couldn't get these stocks lower?

Jim Cramer: Stocks Are on Fire For Good Reasons

Jim Cramer: Stocks Are on Fire For Good Reasons

Stocks put in broad gains supported by tax cuts, bonuses, a weaker dollar and more.

3 More Stocks To Buy on Tax Reform

3 More Stocks To Buy on Tax Reform

Rent-A-Center, Foot Locker and AV Homes will get a nice holiday gift with the tax deal.

7 Hot Investing Bets to Make in Biotech

7 Hot Investing Bets to Make in Biotech

These favorite names in the volatile sector offer the potential for high rewards.

Deciphering Wall Street's Differing Views of Amgen

Deciphering Wall Street's Differing Views of Amgen

What to make of the divergent views of Amgen's shares.

Deciphering the Amgen Enigma

Deciphering the Amgen Enigma

What to make of the divergent views of Amgen.

Some Afternoon Observations

* Thus far, my expectation of an "inside day" has been accurate. SPDR S&P 500 ETF  has traded in a fifty cent range most of the day. * Bonds are at the day's highs. +$0.88. Yield on the 10-year U.S. note is down by 3.5 basis points to 2.32% (where y...

10 Biotech Stocks Investors Should Put on Their Shopping List for 2018

10 Biotech Stocks Investors Should Put on Their Shopping List for 2018

Biotech M&A activity will pick up markedly in 2018, and these companies are likely to be the most active in that space.

10 Biotech Stocks to Watch in 2018

10 Biotech Stocks to Watch in 2018

There are a variety of players that should be active in the M&A space next year.

The Good, the Bad and the Ugly (Monday Edition)

"If you work for a living, why do you kill yourself working?" -- Tuco, The Ugly: "The Good, the Bad and the Ugly" There was plenty of sector rotation today (but little overall movement), so let's move to the abbreviated Monarch Notes form of "Takeaw...